Immunic

-$0.30 (-3.32%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.

About IMUX

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.

CEO
Daniel Vitt
Employees
28
Headquarters
New York, New York
Founded
2003

IMUX Key Statistics

Market Cap
313.90M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
249.05K
High Today
$9.12
Low Today
$8.60
Open Price
$8.91
Volume
175.23K
52 Week High
$28.21
52 Week Low
$8.60

IMUX Earnings

-$1.63
-$1.09
-$0.54
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure